AK Medical Holdings Limited (HKG:1789)
Hong Kong
· Delayed Price · Currency is HKD 6.52
-0.19 (-2.83%)
Apr 29, 2026, 4:08 PM HKT
AK Medical Holdings Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1,482 | 1,346 | 1,094 | 1,052 | 761.44 | Upgrade
|
| Revenue Growth (YoY) | 10.11% | 23.09% | 3.98% | 38.16% | -26.46% | Upgrade
|
| Cost of Revenue | 585.04 | 538.18 | 419.38 | 415.61 | 262.25 | Upgrade
|
| Gross Profit | 897.4 | 808.19 | 674.49 | 636.44 | 499.19 | Upgrade
|
| Selling, General & Admin | 417.58 | 384.86 | 352.25 | 298.42 | 292.66 | Upgrade
|
| Research & Development | 136.02 | 139.21 | 137.13 | 110.87 | 113.07 | Upgrade
|
| Other Operating Expenses | -30.09 | -16.65 | -26.37 | -11.19 | -5.98 | Upgrade
|
| Operating Expenses | 523.52 | 507.41 | 463 | 398.09 | 399.75 | Upgrade
|
| Operating Income | 373.88 | 300.78 | 211.48 | 238.34 | 99.44 | Upgrade
|
| Interest Expense | - | -0.92 | -1.29 | -2.17 | -1.61 | Upgrade
|
| Interest & Investment Income | 26.4 | 23.37 | 22.77 | 17.75 | 8.99 | Upgrade
|
| Currency Exchange Gain (Loss) | -5.3 | -3.41 | -1.85 | 4.73 | 1.74 | Upgrade
|
| EBT Excluding Unusual Items | 394.98 | 319.82 | 231.12 | 258.65 | 108.56 | Upgrade
|
| Impairment of Goodwill | - | - | - | -18.36 | - | Upgrade
|
| Pretax Income | 394.98 | 319.82 | 231.12 | 240.29 | 108.56 | Upgrade
|
| Income Tax Expense | 55.89 | 45.9 | 49.01 | 35.52 | 15.94 | Upgrade
|
| Net Income | 339.09 | 273.93 | 182.1 | 204.77 | 92.62 | Upgrade
|
| Net Income to Common | 339.09 | 273.93 | 182.1 | 204.77 | 92.62 | Upgrade
|
| Net Income Growth | 23.79% | 50.42% | -11.07% | 121.09% | -70.50% | Upgrade
|
| Shares Outstanding (Basic) | 1,117 | 1,116 | 1,113 | 1,109 | 1,113 | Upgrade
|
| Shares Outstanding (Diluted) | 1,120 | 1,119 | 1,119 | 1,117 | 1,121 | Upgrade
|
| Shares Change (YoY) | 0.10% | -0.05% | 0.15% | -0.28% | 1.21% | Upgrade
|
| EPS (Basic) | 0.30 | 0.25 | 0.16 | 0.18 | 0.08 | Upgrade
|
| EPS (Diluted) | 0.30 | 0.24 | 0.16 | 0.18 | 0.08 | Upgrade
|
| EPS Growth | 26.25% | 50.00% | -11.11% | 125.00% | -71.43% | Upgrade
|
| Free Cash Flow | - | 298.25 | -149.86 | 127.72 | 117.86 | Upgrade
|
| Free Cash Flow Per Share | - | 0.27 | -0.13 | 0.11 | 0.10 | Upgrade
|
| Dividend Per Share | 0.106 | 0.068 | 0.041 | 0.053 | 0.020 | Upgrade
|
| Dividend Growth | 56.73% | 65.64% | -23.04% | 160.59% | -39.53% | Upgrade
|
| Gross Margin | 60.54% | 60.03% | 61.66% | 60.49% | 65.56% | Upgrade
|
| Operating Margin | 25.22% | 22.34% | 19.33% | 22.66% | 13.06% | Upgrade
|
| Profit Margin | 22.87% | 20.34% | 16.65% | 19.46% | 12.16% | Upgrade
|
| Free Cash Flow Margin | - | 22.15% | -13.70% | 12.14% | 15.48% | Upgrade
|
| EBITDA | 450.79 | 377.69 | 282.36 | 300.3 | 156.85 | Upgrade
|
| EBITDA Margin | 30.41% | 28.05% | 25.81% | 28.54% | 20.60% | Upgrade
|
| D&A For EBITDA | 76.91 | 76.91 | 70.88 | 61.95 | 57.42 | Upgrade
|
| EBIT | 373.88 | 300.78 | 211.48 | 238.34 | 99.44 | Upgrade
|
| EBIT Margin | 25.22% | 22.34% | 19.33% | 22.66% | 13.06% | Upgrade
|
| Effective Tax Rate | 14.15% | 14.35% | 21.21% | 14.78% | 14.68% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.